The development of a technology-based information support intervention (iSupport) among patients with differentiated thyroid cancer post radioactive iodine therapy
针对放射性碘治疗后分化型甲状腺癌患者开发基于技术的信息支持干预 (iSupport)
基本信息
- 批准号:10581121
- 负责人:
- 金额:$ 13.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-02 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAftercareAppointmentBehavior TherapyBehavioralBehavioral ModelCancer ControlCancer PatientCaringCellular PhoneClinicalClinical Trials DesignComputersControl GroupsCoping SkillsDataDevelopmentDevicesDiagnosisDistressEducationEducational InterventionEligibility DeterminationEndocrineEnrollmentEuropean Organization for Research and Treatment of CancerEvidence based interventionFeedbackFocus GroupsFollicular thyroid carcinomaFrequenciesFrustrationFunctional disorderFutureGoalsGoldGrantIndividualInformation ManagementInterventionInterviewKnowledgeLacrimal gland structureLate EffectsLeadershipMalignant NeoplasmsMalignant neoplasm of thyroidMeasuresMentorsMentorshipNoseOnline SystemsOral healthPainPapillary CarcinomaParticipantPatient SelectionPatient-Focused OutcomesPatientsPersonsPhasePopulationPrognosisProviderRadioactive IodineRandomizedRandomized, Controlled TrialsRecommendationReportingResearchResearch DesignResearch PersonnelSalivarySalivary GlandsSecond Primary CancersSelf EfficacySleepSocial FunctioningStressSurvival RateSymptomsSystemTechnologyTestingTrainingTreatment EfficacyTreatment Side EffectsWritingacceptability and feasibilityalternative treatmentcancer therapycancer typecareer developmentcommon symptomcopingdesigndigital healthdigital technologyempowermentexperiencefollow-uphealth related quality of lifeimprovedintervention effectlacrimalnoveloral mucositispatient populationpilot testprimary outcomeradioiodine therapyreduce symptomssecondary outcomeside effectskillssocial cognitive theorysupport toolssurvival outcomesurvivorshipsymptom managementsymptom treatmenttherapy designtherapy developmenttooltreatment as usualtreatment comparisontreatment effectunderstudied cancerusabilityweb-based intervention
项目摘要
Abstract
Radioactive iodine (RAI) therapy is routinely used among patients diagnosed with differentiated thyroid cancer
(DTC), with approximately 76% of patients receiving RAI. Patients with DTC post RAI treatment report
extensive short-term and late effects of treatment, symptom burden, and unmet informational needs about
treatment related side effects. However, thyroid cancer is frequently referred to as the “good cancer” and is an
understudied cancer population for survivorship research and web-based interventions. One way to address
these gaps is through digital technologies such as a web-based intervention, which can empower patients with
direct access to educational and support tools to reduce symptom burden. I propose to develop and evaluate a
web-based intervention, called iSupport (informational support among patients post RAI treatment), to reduce
symptom burden among patients diagnosed with DTC post RAI. I propose the following aims: Aim 1 (K99).
Develop iSupport, a web-based intervention, for patients with DTC post RAI therapy. Aim 2 (K99). Test the
usability of the newly developed iSupport intervention among patients with DTC post RAI. Aim 3 (R00).
Assess the feasibility and acceptability of the iSupport intervention. Aim 4 (R00). Test the preliminary efficacy
of the iSupport intervention vs. treatment as usual (TAU) among patients with DTC on symptom burden. The
K99 phase will involve: 1) conducting patient focus groups (N=32) and individual stakeholder interviews (N=12)
to develop iSupport and 2) testing the usability of the iSupport intervention among patients with DTC post RAI
therapy (N=8). The R00 phase will involve conducting a pilot randomized controlled trial (RCT; N=72) to: 1)
assess the feasibility and acceptability of iSupport and 2) test the preliminary efficacy of iSupport compared to
a (TAU) control group with DTC patients on RAI-related symptom burden, patient bioheath indicators (oral
mucositis; oral health problems), knowledge of DTC and RAI, self-efficacy for coping with side effects, cancer-
related distress, and health-related quality of life. The overall objective of the K99/R00 is to provide Dr. Carr
with training and mentorship to become an independent cancer control investigator with expertise in digital
technology evidenced-based interventions among cancer patients. The K99 training goals include: 1) increase
knowledge of clinical concerns and symptoms among patients with DTC post RAI, 2) obtain advanced training
in technology-based intervention design and development, 3) develop expertise in behavioral intervention
clinical trials design and testing, and 4) refine grant writing and leadership skills for future independence. Dr.
Carr’s mentorship team includes Drs. Kristi Graves (primary), Jacqueline Jonklaas (co-mentor), and Kristen
Miller (co-mentor) who are committed to her career development. The proposed training plan will facilitate Dr.
Carr’s transition to independence as a cancer control researcher with expertise in digital health interventions to
reduce symptom burden and improve health-related quality of life in cancer patient outcomes after treatment.
摘要
放射性碘(RAI)治疗是诊断为分化型甲状腺癌患者的常规治疗方法。
(DTC),大约76%的患者接受RAI。RAI治疗后DTC患者报告
治疗的广泛短期和晚期影响、症状负担和未得到满足的信息需求
与治疗相关的副作用。然而,甲状腺癌通常被称为“良癌”,是一种
未充分研究癌症人群的生存研究和基于网络的干预。一种解决问题的方法
这些差距是通过数字技术实现的,例如基于网络的干预,它可以赋予患者
直接访问教育和支持工具,以减轻症状负担。我建议开发和评估一个
基于网络的干预,称为iSupport(RAI治疗后患者的信息支持),以减少
RAI后诊断为DTC的患者的症状负担。我提出以下目标:目标1(K99)。
为RAI治疗后DTC患者开发iSupport,这是一种基于网络的干预措施。目标2(K99)。测试
新开发的iSupport干预在RAI后DTC患者中的可用性。目标3(R00)。
评估iSupport干预的可行性和可接受性。目标4(R00)。初步药效试验
在DTC患者的症状负担方面,iSupport干预与常规治疗(TAU)的比较。这个
K99阶段将包括:1)开展患者焦点小组(N=32)和个人利益相关者访谈(N=12)
开发iSupport和2)测试iSupport在RAI后DTC患者中的可用性
治疗组(N=8)。R00阶段将包括进行试点随机对照试验(RCT;N=72)至:1)
评估iSupport的可行性和可接受性,以及2)测试iSupport与
A组(TAU)为对照组,对DTC患者RAI相关症状负荷、患者生物健康指标(口服
粘膜炎;口腔健康问题),DTC和RAI的知识,应对副作用的自我效能,癌症-
相关的痛苦和与健康相关的生活质量。K99/R00的总体目标是为Carr博士提供
通过培训和指导,成为拥有数字专业知识的独立癌症控制调查员
在癌症患者中进行以技术为基础的干预。K99培训目标包括:1)增加
对RAI后DTC患者的临床关注和症状的知识,2)接受高级培训
在基于技术的干预设计和开发中,3)开发行为干预方面的专业知识
临床试验设计和测试,以及4)完善未来独立性的拨款撰写和领导技能。Dr。
卡尔的导师团队包括Kristi Graves博士(主要导师)、Jacqueline Jonklaas博士(共同导师)和Kristen
米勒(共同导师)致力于她的职业发展。拟议的培训计划将为Dr。
作为一名癌症控制研究人员,卡尔过渡到独立,拥有数字健康干预方面的专业知识
减轻癌症患者治疗后症状负担,提高与健康相关的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alaina L Carr其他文献
Alaina L Carr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 13.1万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 13.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 13.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 13.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




